Featured Products
Product News
New Collaboration Explores Efficacy of Gene Delivery Vector Tech in Diabetes and Multiple Sclerosis
Amarna Therapeutics has announced today that it has entered into a collaboration with scientists from the Progreso y Salud Foundation (FPS) at Cabimer in Seville, to jointly examine the efficacy of Amarna’s SVec™ gene delivery vector for the development of effective immunotherapies for diabetes mellitus type 1 (DM1) and multiple sclerosis (MS).
READ MORE
First Data on Using a Therapeutic Form of ACE2 To Treat COVID-19 Published
A case report published today in The Lancet Respiratory Medicine outlines the first compassionate use of recombinant soluble human ACE2 (APN01) to treat a female 45-year-old patient who was diagnosed with severe COVID-19.
READ MORE
Canada’s Largest Research Hospital Selects ImmunoGenomiX Platform To Analyze Immune Sequencing Data
ENPICOM, an innovative bioinformatics software engineering company specialized in decoding the immune system, announced that the Princess Margaret Cancer Centre of the University Health Network (UHN) has purchased a subscription to ENPICOM’s data analysis platform.
READ MORE
ERS Genomics Announces Agreement With Applied StemCell To Commercialize CRISPR Gene Editing Solutions
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property announced it has signed an agreement with Applied StemCell, Inc., a leading provider of stem cell, animal model, antibody discovery services and reagents to commercialize CRISPR gene editing.
READ MORE
PCR Biosystems Launches RiboShield™ RNase Inhibitor
PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product.
READ MORE
Genomic Leaders To Create Australia’s First National COVID-19 Tracking System
Illumina announced today that the Australian public health laboratories will aim to sequence the virus genomes of all positive COVID-19 tests in Australia and track COVID-19 using genomics across the country, rather than state by state, under a ground-breaking initiative spearheaded by Australia’s public health laboratory organisations and leading industry partners.
READ MORE
Promega and Hitachi High-Tech Launch Spectrum Compact CE Benchtop DNA Analysis Instrument
Promega has launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech.
READ MORE
Daicel Arbor Launches Improved myBaits Protocol
Daicel Arbor has announced an advance in the latest myBaits kit reagent chemistry and associated protocol referred to as myBaits Version 5.
READ MORE
Thermo Fisher Introduces Hematology-Oncology Portfolio for Rapid NGS Results
Thermo Fisher Scientific has announced a new portfolio of hematology-oncology assays for the Ion Torrent Genexus System designed to enable a future in which turnaround times for next-generation sequencing results can be reduced to less than 24 hours.
READ MORE
Thermo Fisher’s COVID-19 Response Expanded With High-Throughput Automated Testing Solution
Thermo Fisher Scientific Inc. has introduced a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day to meet increasing global demand for COVID-19 testing.
READ MORE
